Adjuvant Systemic Therapy for High-Risk Melanoma

Ann Surg Oncol. 2023 May;30(5):2568-2569. doi: 10.1245/s10434-023-13105-2. Epub 2023 Jan 20.

Authors

Sonia Cohen¹, Kenneth K Tanabe²

Affiliations

¹ Division of Gastrointestinal and Oncologic Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA.
² Division of Gastrointestinal and Oncologic Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA. ktanabe@partners.org.

PMID: 36670279
DOI: 10.1245/s10434-023-13105-2

No abstract available

Publication types

Editorial

MeSH terms

Adjuvants, Immunologic / therapeutic use
Chemotherapy, Adjuvant
Combined Modality Therapy
Humans
Melanoma* / drug therapy
Skin Neoplasms* / drug therapy

Substances

Adjuvants, Immunologic